FDA Inspection
Fresenius Kabi USA LLCFresenius Kabi USA LLC – FDA Inspection, Aug 24, 2023
Record Details
This FDA Inspection record concerns Fresenius Kabi USA LLC, with an inspection on August 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 36556a19-8f7e-4700-8789-57d67d5eb31b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1216183
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Fresenius Kabi USA LLC
14| Date | Classification | Office | Project area |
|---|---|---|---|
| February 18, 2026 | Not classified | Chicago District Office | |
| June 30, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 3, 2018 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| September 18, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Fresenius Kabi USA LLC
- FDA Inspection 1311592 - 2026-02-18
- FDA Inspection 1174894 - 2022-06-30
- FDA Inspection 1123748 - 2020-05-18
- FDA Inspection 1075139 - 2018-12-03
- FDA Inspection 943126 - 2015-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.